Whalegun
Home

Gwenn Hansen, Chief Scientific Officer: Nurix Therapeutics NRIX Sell · Filed 01/30

Trade details

Type
Insider sale
Amount
$79,534.26
Shares · price
4,797 sh · $16.58 a share
Held after
83,770 sh
Stock
Nurix Therapeutics NRIX
Person
Gwenn HansenChief Scientific Officer
Trade date
26/01/30
Filed
26/01/30
Days to filing
0 days

Sold 5.4% of holdings

Share of holding sold
5.4%

Nurix Therapeutics trades, last 26 weeks

What else happened in Nurix Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/31~03/01

Gwenn Hansen's recent trades

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $215.1K

    Filed 08/05

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $95.5K

    Filed 08/04

  • Gwenn Hansen

    Sell10b5-1 planNurix Therapeutics

    $107.9K

    Filed 06/25

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $104.1K

    Filed 06/25

  • Gwenn Hansen

    SellNurix Therapeutics

    $53.5K

    Filed 04/30

Gwenn Hansen, Chief Officer — sold $79.5K of Nurix Therapeutics NRIX · 5.4% of holdings | Whalegun